14 May, 2024 | Online

17:00-18:00 CEST

Chairs: Dr Stefan Unger (Edinburgh, United Kingdom), Dr Nadine Freitag (Krefeld, Germany)
Speakers: Prof. Dr Timothy Hinks (Oxford, United Kingdom), Prof. Andrew Bush (London, United Kingdom)

Overview

Azithromycin is frequently used in paediatric and adult respiratory medicine.

Educating healthcare professions and researchers about the evidence for the antibacterial, anti-inflammatory and antiviral properties of azithromycin to provide a better understanding of the bases for use in a variety of acute and chronic respiratory diseases, both in adult and paediatric medicine. It helps the audience to apply the knowledge to every day practice and highlight areas where further research is required.

Educational aims

The webinar will provide details for the use of azithromycin in respiratory diseases including:

• Asthma
• Viral infections
• Chronic suppurative lung diseases including bronchiectasis and PCD

The webinar will help participants to develop a better understanding of the drug actions and impact in clinical practice.

Topics

• Azithromycin in asthma and viral infections
• Antiviral and anti-inflammatory properties of azithromycin in cystic fibrosis
• Azithromycin in Chronic Suppurative Lung Disease

Target audience

• Paediatric respiratory consultants
• Adult respiratory consultants
• Paediatric and adult respiratory medicine trainees
• Paediatric and adult respiratory nurses and physiotherapists

Learning outcomes

Following this webinar, participants will be able to:

• Have an understanding of the antibacterial, anti-inflammatory and antiviral properties of azithromycin
• Understand the role of azithromycin in some of the major respiratory diseases
• Recognise limitation of our knowledge on the mechanisms of the drug
• Recognise potential side effects and concerns regarding antimicrobial resistance
• Have an understanding of some of the guidelines regarding azithromycin use in practice